These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 33068525)

  • 21. Five-minute point-of-care testing for SARS-CoV-2: Not there yet.
    Hogan CA; Sahoo MK; Huang C; Garamani N; Stevens B; Zehnder J; Pinsky BA
    J Clin Virol; 2020 Jul; 128():104410. PubMed ID: 32403009
    [No Abstract]   [Full Text] [Related]  

  • 22. Saliva as a Noninvasive Specimen for Detection of SARS-CoV-2.
    Williams E; Bond K; Zhang B; Putland M; Williamson DA
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32317257
    [No Abstract]   [Full Text] [Related]  

  • 23. COVID-19 spurs wave of innovative diagnostics.
    Sheridan C
    Nat Biotechnol; 2020 Jul; 38(7):769-772. PubMed ID: 32641849
    [No Abstract]   [Full Text] [Related]  

  • 24. Polymorphic cutaneous manifestations of COVID-19 infection in a single viral host.
    Patel N; Kho J; Smith KE; Ahmed A; Van den Abbeele K; Mandal AKJ; Missouris CG
    Int J Dermatol; 2020 Sep; 59(9):1149-1150. PubMed ID: 32686096
    [No Abstract]   [Full Text] [Related]  

  • 25. Coronavirus disease (COVID-19) Community Testing Team in Scotland: A 14-day review, 6 to 20 February 2020.
    Mark K; Steel K; Stevenson J; Evans C; McCormick D; Willocks L; McCallum A; Jones L; Johannessen I; Templeton K; Koch O; Mackintosh C
    Euro Surveill; 2020 Mar; 25(12):. PubMed ID: 32234116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interpreting Diagnostic Tests for SARS-CoV-2.
    Sethuraman N; Jeremiah SS; Ryo A
    JAMA; 2020 Jun; 323(22):2249-2251. PubMed ID: 32374370
    [No Abstract]   [Full Text] [Related]  

  • 27. Sample collection and stabilization from saliva samples for SARS-CoV-2 detection by qPCR.
    Biotechniques; 2020 Sep; 69(3):237. PubMed ID: 32929994
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluation of a Rapid Diagnostic Assay for Detection of SARS-CoV-2 Antigen in Nasopharyngeal Swabs.
    Lambert-Niclot S; Cuffel A; Le Pape S; Vauloup-Fellous C; Morand-Joubert L; Roque-Afonso AM; Le Goff J; Delaugerre C
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32404480
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation of Testing Frequency and Sampling for Severe Acute Respiratory Syndrome Coronavirus 2 Surveillance Strategies in Long-Term Care Facilities.
    Lanièce Delaunay C; Saeed S; Nguyen QD
    J Am Med Dir Assoc; 2020 Nov; 21(11):1574-1576.e2. PubMed ID: 32994117
    [No Abstract]   [Full Text] [Related]  

  • 30. Chilblains-like dermatologic manifestation of COVID-19 diagnosed by serology via multidisciplinary virtual care.
    Kerber AA; Soma DB; Youssef MJ
    Int J Dermatol; 2020 Aug; 59(8):1024-1025. PubMed ID: 32496578
    [No Abstract]   [Full Text] [Related]  

  • 31. Coronavirus disease 2019 outbreak.
    Patrucco F; Gavelli F; Shi R; De Vita N; Pavot A; Castello LM; Ravanini P; Balbo PE
    Panminerva Med; 2020 Jun; 62(2):73-74. PubMed ID: 32208412
    [No Abstract]   [Full Text] [Related]  

  • 32. The treatment and outcome of a pulmonary sarcomatoid carcinoma patient infected with SARS-CoV-2.
    Wang K; Liu Y; Hu T; Liu Y; Liu C
    Lung Cancer; 2020 Aug; 146():373-375. PubMed ID: 32563532
    [No Abstract]   [Full Text] [Related]  

  • 33. Coronavirus Disease 2019 Test Results After Clinical Recovery and Hospital Discharge Among Patients in China.
    Wu J; Liu X; Liu J; Liao H; Long S; Zhou N; Wu P
    JAMA Netw Open; 2020 May; 3(5):e209759. PubMed ID: 32442288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. My Experience with SARS-CoV-2, with a Focus on Testing.
    Cotter PA
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32703893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid Detection of Asymptomatic Coronavirus Disease 2019 by Computed Tomography Image Guidance for Stereotactic Ablative Radiotherapy.
    McGinnis GJ; Ning MS; Nitsch PL; O'Reilly MS; McAleer MF; Koong AC; Chang JY
    J Thorac Oncol; 2020 Jun; 15(6):1085-1087. PubMed ID: 32311499
    [No Abstract]   [Full Text] [Related]  

  • 36. Covid-19 mass testing facilities could end the epidemic rapidly.
    Peto J
    BMJ; 2020 Mar; 368():m1163. PubMed ID: 32201376
    [No Abstract]   [Full Text] [Related]  

  • 37. Chilblain-like lesions during the COVID-19 pandemic: early or late sign?
    Recalcati S; Fantini F
    Int J Dermatol; 2020 Aug; 59(8):e268-e269. PubMed ID: 32572958
    [No Abstract]   [Full Text] [Related]  

  • 38. Cutaneous lesions in a patient with COVID-19: are they related?
    Ahouach B; Harent S; Ullmer A; Martres P; Bégon E; Blum L; Tess O; Bachmeyer C
    Br J Dermatol; 2020 Aug; 183(2):e31. PubMed ID: 32353170
    [No Abstract]   [Full Text] [Related]  

  • 39. Viral load of SARS-CoV-2 in clinical samples.
    Pan Y; Zhang D; Yang P; Poon LLM; Wang Q
    Lancet Infect Dis; 2020 Apr; 20(4):411-412. PubMed ID: 32105638
    [No Abstract]   [Full Text] [Related]  

  • 40. Saliva as an Alternate Specimen Source for Detection of SARS-CoV-2 in Symptomatic Patients Using Cepheid Xpert Xpress SARS-CoV-2.
    McCormick-Baw C; Morgan K; Gaffney D; Cazares Y; Jaworski K; Byrd A; Molberg K; Cavuoti D
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32414838
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.